Pharmaceutical compositions that act as adenosine receptor antagonist which cures liver diseases, such as Nonalcoholic steatohepatitis (NASH), liver fibrosis, cirrhosis of liver containing adenosine d
|Title||Pharmaceutical compositions that act as adenosine receptor antagonist which cures liver diseases, such as Nonalcoholic steatohepatitis (NASH), liver fibrosis, cirrhosis of liver containing adenosine d|
|Profile Type||Technology Request|
A bio-venture Korean SME has developed first-in-class drug synthesis since established in 2015, and the company represents new drug candidates that have an efficiency of relief on Nonalcoholic Steatohepatitis, Liver Fibrosis, and Liver Cirrhosis, which are called Adenosine Receptor Antagonist. The company came up with the idea due to lack of pharmaceutical treatment for NASH. The company is, thus, open to take the partnership of license and commercial agreement with technical assistant.
|Type and Role of Partner Sought|
- Type of partner sought: Companies have professional perspectives on pharmaceutical materials.
- Specific area of activity of the partner: The partners should be specialized in the industry of pharmaceutical, and also interested in developing new drug candidates.
- Task to be performed: The company has on-going research of pharmaceutical products and drugs related to non-alcoholic liver diseases, and they would like to focus on developing new medication under commercial agreement with technical assistant, and license agreement would make the new developed drugs be used in pharmaceutical industry.
|Type of Partnership Considered|
Commercial Agreement with Technical Assistance, License Agreement
|Technology Keyword||drug , pharmaceutical , technology|
|EEN Application File||EEN Application File TRKR20180723001.PDF |
The profile provides the summary only. For the profile details, please download the application file in PDF.